Please login to the form below

Not currently logged in

EFPIA confirms first and second vice-presidents

Novo Nordisk CEO Lars Fruergaard Jørgensen appointed first vice-president and Servier president Olivier Laureau confirmed as second vice-president

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has confirmed Lars Fruergaard Jørgensen (pictured above, left) as its new first vice-president and Olivier Laureau (pictured above, right) as second vice-president.

Fruergaard Jørgensen currently serves as the president and chief executive officer of Novo Nordisk, while Laureau serves as president of French pharma company Servier.

Commenting on his appointment, Jørgensen said: “From an ageing population and the burden of chronic disease, to environmental sustainability and fiscal constraints, we are committed to tackling societal challenges in partnership.

“That includes working with governments to reduce access delays and improve the availability of medicines for patients across Europe.  I look forward to working with the EFPIA Board and the wider community to achieve the shared goal of building a future EU health and innovation union.”

Meanwhile, Laureau said: “Recent events have demonstrated the key role medical innovation plays in keeping our society safe and healthy.  Our ambition is for Europe to be a world leader in life science.

“Realising that goal means EFPIA and its membership working with the EU and Member States to build a world-class regulatory system, a strong and predictable IP framework and a next generation life sciences eco-system that delivers for patients across Europe and around the world.”

The EFPIA also confirmed Hubertus von Baumbach, chairman of the board of managing directors at Boehringer Ingelheim, as president for the next two years.

Article by
Lucy Parsons

24th June 2021

From: Regulatory


Subscribe to our email news alerts


Add my company
Research Partnership

Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....